Published in

Mary Ann Liebert, Thyroid, 12(23), p. 1600-1608, 2013

DOI: 10.1089/thy.2013.0194

Links

Tools

Export citation

Search in Google Scholar

Effects of Prostaglandin F<sub>2α</sub>on Adipocyte Biology Relevant to Graves' Orbitopathy

Journal article published in 2013 by Mohd Shazli Draman, Fiona Grennan-Jones, Lei Zhang, Peter N. Taylor, Tommy Kyaw Tun, John McDermott, Paul Moriarty, Daniel Morris, Carol Lane, Seamus Sreenan, Colin Dayan, Marian Ludgate ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background: In Graves' orbitopathy (GO), increased proliferation, excess adipogenesis, and hyaluronan overproduction produce GO exophthalmos. Enophthalmos occurs in some glaucoma patients treated with Bimatoprost (prostaglandin F2α, PGF2α) eye drops. We hypothesized that enophthalmos is secondary to reductions in orbital tissue proliferation, adipogenesis, and/or increased lipolysis. We aimed to determine which of these is affected by PGF2α by using the 3T3-L1 murine preadipocyte cell line and primary human orbital fibroblasts (OFs) from GO patients (n=5) and non-GO (n=5).